MLchartDataset catalogue

prodencel

Term · Oncology and biomedicine · MLC-T-ONC-016237

An autologous dendritic cell (DC) vaccine targeting prostate cancer (PC)-specific antigen(s), with potential immunostimulatory and antineoplastic activities. Upon administration of prodencel, the DCs stimulate a specific cytotoxic T-lymphocyte (CTL)-mediated immune response against PC cells expressing the antigen(s), resulting in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-016237
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-016237",
  "term": "prodencel",
  "field": "Oncology and biomedicine",
  "definition": "An autologous dendritic cell (DC) vaccine targeting prostate cancer (PC)-specific antigen(s), with potential immunostimulatory and antineoplastic activities. Upon administration of prodencel, the DCs stimulate a specific cytotoxic T-lymphocyte (CTL)-mediated immune response against PC cells expressing the antigen(s), resulting in tumor cell lysis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/prodencel/"
}

Record 13,667 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.